SonoSite Highlights New Patient Safety Technology and Other Advances for Vascular Access Applications
September 14 2009 - 3:30PM
Business Wire
SonoSite, Inc. (Nasdaq:SONO), the world leader and
specialist in hand-carried and point-of-care ultrasound, announced
today new patient safety technology, mobile power solutions and
image quality advances for vascular access applications. The
company will be showcasing the new products and capabilities at the
annual scientific meeting of the Association for Vascular Access
(AVA) being held in Las Vegas September 14th - 18th, 2009.
THE NANOMAXX™ ULTRASOUND SYSTEM
SonoSite will be showing the 6-pound NanoMaxx ultrasound tool1,
the latest addition to its suite of specialized products for
point-of-care visualization in medicine. Combining one-button
optimization technology with a fluid resistant touch screen user
interface, the NanoMaxx system is highly sophisticated, easy to use
and easy to disinfect. While other touch screens require a stylet
to activate system controls, the sensitivity of the NanoMaxx touch
screen allows the user to operate the system with the touch of a
finger while wearing sterile gloves. The image quality and color
flow mapping on the NanoMaxx provide increased utility versus
alternatives by giving users the ability to identify nerve bundles
and distinguish veins from arteries, delivering the visualization
needed for safe and effective line placements.
“The NanoMaxx is just the system that we have been waiting for,”
said Patricia Santulli, R.T.R., R.N., BSN, and PICC Line
Coordinator at Harborview Medical Center, Seattle. “With its high
resolution, it will be easy to avoid accidentally puncturing a
nerve. The one button control and touch screen are ideal and its
small size will make it easy to fit into crowded spaces or rest on
the patient’s bed.”
As with SonoSite’s other advanced ultrasound products, the
NanoMaxx system and its transducers exceed military specifications
for ruggedness and durability and are built to withstand a 3-foot
drop onto a hard surface. The NanoMaxx system is backed by
SonoSite’s industry-leading, standard 5-year warranty, eliminating
the expense for an annual service contract.
LUMENVU™ CATHETER GUIDANCE SYSTEM
At the AVA, SonoSite will also be showing as a works-in-progress
its LumenVu Catheter Guidance System, for visualizing the placement
of Peripherally Inserted Central Catheters (PICC) at the
point-of-care. SonoSite expects to begin shipping LumenVu systems
at the end of 2009, subject to FDA 510(k) clearance. The LumenVu
system couples near infrared light with standard catheter
technology to enable visual tracking of a catheter tip in real time
as it advances from the access vein to the superior vena cava.
SonoSite’s ultimate goal is to reduce or potentially eliminate the
need for x-ray and/or fluoroscopy to confirm accurate line
placement in hospital environments.
Incorrect catheter insertion is relatively common with bedside
placement of PICC lines and reinsertion adds considerable time and
cost. A recent large study showed only 70% of insertions were
successful on the first attempt.2 As a result, the company believes
that this technology could offer cost reduction and safety
opportunities for hospitals and other provider environments where
PICC lines are inserted. For more information on the LumenVu
system, visit http://www.sonosite.com/lumenvu/.
SONOSITE® MOBILE POWER SOLUTIONS – POWER PORT AND POWER
PACK
To ensure true mobility at all times to point-of-care locations
around a hospital, SonoSite is offering innovative, integrated
power solutions with its new ergonomic Universal Stands.
Configurable with the M-Turbo®, S Series™, NanoMaxx™ and MicroMaxx®
product lines, SonoSite’s Universal Stands are light, easy to
configure and highly maneuverable in the hospital setting and can
be optimally positioned by the patient beside or in other
space-constrained areas.
SonoSite’s Power Port eliminates the need for connecting
a system docked in its stand to an electrical outlet and instead
allows the user to simply charge the system when it’s parked in the
Power Port. SonoSite’s Power Pack triples battery life and
can keep a system charged for 6 hours or more allowing clinicians
the flexibility needed to see more patients on a single charge. The
Power Pack is easily installed on the column of the Universal
Stand.
NEW TRANSDUCER TECHNOLOGY FOR M-TURBO SYSTEM
SonoSite will also introduce new technology for linear array
transducers at the AVA. Sono UltraRes™ technology uses a broader
frequency range to present improved spatial resolution and contrast
resolution while maintaining penetration. This harnesses the
benefits of high frequencies for image quality and the benefits of
low frequencies for penetration to provide a better looking image
and increased versatility overall. Sono UltraRes technology will be
an important image enhancement for clinicians using linear array
transducers.
About SonoSite
SonoSite, Inc. (www.sonosite.com) is the innovator and world
leader in hand-carried ultrasound. Headquartered near Seattle, the
company is represented by ten subsidiaries and a global
distribution network in over 100 countries. SonoSite’s small,
lightweight systems are expanding the use of ultrasound across the
clinical spectrum by cost-effectively bringing high performance
ultrasound to the point of patient care. The company employs
approximately 750 people worldwide.
Forward-looking Information and the Private Litigation Reform
Act of 1995
Certain statements in this press release relating to the
potential benefits of SonoSite’s future products and technology are
“forward-looking statements” for the purposes of the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
These forward-looking statements are based on the opinions and
estimates of our management at the time the statements are made and
are subject to risks and uncertainties that could cause actual
results to differ materially from those expected or implied by the
forward-looking statements. These statements are not guaranties of
future performance, are based on potentially inaccurate assumptions
and are subject to known and unknown risks and uncertainties,
including, without limitation, the risk that these products and
technology will not yield the expected potential benefits, and the
other factors contained in Item 1A. “Risk Factors” section of our
most recent Annual Report on Form 10-K filed with the Securities
and Exchange Commission. We caution readers not to place undue
reliance upon these forward-looking statements that speak only as
to the date of this release. We undertake no obligation to publicly
revise any forward-looking statements to reflect new information,
events or circumstances after the date of this release or to
reflect the occurrence of unanticipated events.
1 Availability in the US pending FDA 510(k) clearance.
2 Trerotola, S.O., Thompson, S., Chittams, J., Vierregger, K.S.
Analysis of Tip Malposition and Correction in Peripherally Inserted
Central Catheters Placed at Bedside by a Dedicated Nursing Team. J
Vasc Interv Radiol 2007; 18: 513-518.
Sonos (NASDAQ:SONO)
Historical Stock Chart
From Jun 2024 to Jul 2024
Sonos (NASDAQ:SONO)
Historical Stock Chart
From Jul 2023 to Jul 2024